关键数据
1.560今开
1.570最高
11.50K成交量
亏损市盈率 TTM
--市盈率动
--股息TTM
0.38%换手率
1.590昨收
1.465最低
8.82K成交额
亏损市盈率静
1.37市净率
0.00%股息率 TTM
-68.12%ROA
4.60052周最高
1.25量比
-4.97M净利润
3.03M总股本
-1.6136每股收益TTM
0.30Beta
-94.32%ROE
1.86652周最低
6.60%振幅
-4.46%毛利率
4.54M总市值
-2.78回报/风险
3.29%风险率
操作建议
Biomerica Inc当前公司基本面数据相对非常健康,增长潜力稳定。当前估值合理,在医疗设备与耗材行业排名140/199位。机构持股占比非常高,中期看,股价处于下降通道。近一个月,市场表现较差,基本面和技术面综合得分也较低。目前股价在压力位和支撑位之间,可以做区间波段操作。
压力支撑

由于公司未披露,未能获取相关数据
Biomerica Inc新闻
即将为您带来更多新闻,敬请期待。。。
技术指标
财务指标
每股收益

由于公司未披露,未能获取相关数据
营业总收入

由于公司未披露,未能获取相关数据
Biomerica Inc简介
Biomerica, Inc. is a biomedical technology company that develops, patents, manufactures and markets advanced diagnostic and therapeutic products. Its diagnostic test kits are utilized in the analysis of blood, urine, nasal, or fecal samples for the diagnosis of various diseases, food intolerances, and other medical conditions. Its range of medical diagnostic products is sold primarily in two markets: clinical laboratories and point-of-care settings, including physicians’ offices and over-the-counter sales. It is focused on research and development efforts and is its patented diagnostic-guided therapy (DGT) product, developed on the in Foods technology platform. Its inFoods IBS product, uses a simple blood test to identify patient-specific foods that, when eliminated, may alleviate IBS symptoms such as pain, bloating, diarrhea, cramping, and constipation. Its hp+detect, a new diagnostic test for detecting Helicobacter pylori (H. pylori) bacteria in the gastrointestinal tract.
公司代码BMRA
公司Biomerica Inc
CEOIrani (Zackary S)
网址https://biomerica.com/
公司股东
常见问题
Biomerica Inc(BMRA)的当前股价是多少?
Biomerica Inc(BMRA)的当前股价是 1.50。
Biomerica Inc股票的52周最高点是多少?
Biomerica Inc股票的52周最高点是4.60。
Biomerica Inc股票的52周最低点是多少?
Biomerica Inc股票的52周最低点是1.87。
Biomerica Inc(BMRA)股票的每股收益(EPS TTM)是多少
Biomerica Inc(BMRA)股票的每股收益(EPS TTM)是-2.16。